To include your compound in the COVID-19 Resource Center, submit it here.
Myrexis retained Stifel Nicolaus Weisel to evaluate strategic alternatives. Myrexis also suspended development of
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury